L.-O. Andersson

1.5k total citations · 1 hit paper
30 papers, 1.3k citations indexed

About

L.-O. Andersson is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, L.-O. Andersson has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in L.-O. Andersson's work include Platelet Disorders and Treatments (11 papers), Blood properties and coagulation (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). L.-O. Andersson is often cited by papers focused on Platelet Disorders and Treatments (11 papers), Blood properties and coagulation (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). L.-O. Andersson collaborates with scholars based in Sweden, United Kingdom and France. L.-O. Andersson's co-authors include E. Holmer, Edward A. Johnson, Håkan Borg, T W Barrowcliffe, G.E.C. Sims, Marianne Mikaelsson, James E. Brown, G.F. Soderstrom, H Sandberg and Trevor W. Barrowcliffe and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and Biochemical Journal.

In The Last Decade

L.-O. Andersson

29 papers receiving 1.2k citations

Hit Papers

Anticoagulant properties of heparin fractionated by affin... 1976 2026 1992 2009 1976 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.-O. Andersson Sweden 14 527 335 321 237 211 30 1.3k
D. Dupouy France 20 356 0.7× 259 0.8× 230 0.7× 241 1.0× 255 1.2× 48 1.0k
G.M. Oosta United States 9 319 0.6× 352 1.1× 445 1.4× 139 0.6× 90 0.4× 15 1000
Herbert C. Whinna United States 25 781 1.5× 396 1.2× 240 0.7× 112 0.5× 249 1.2× 41 1.7k
Todd M. Getz United States 17 610 1.2× 291 0.9× 49 0.2× 102 0.4× 136 0.6× 32 1.2k
Mark W.C. Hatton Canada 15 134 0.3× 363 1.1× 85 0.3× 98 0.4× 40 0.2× 46 850
Gérard Marguerie France 22 581 1.1× 609 1.8× 110 0.3× 135 0.6× 15 0.1× 31 1.6k
Jimmy D. Page United States 14 329 0.6× 310 0.9× 41 0.1× 80 0.3× 78 0.4× 20 981
Elena Tourkina United States 22 170 0.3× 632 1.9× 359 1.1× 72 0.3× 20 0.1× 32 1.4k
Jacqueline Tapon‐Bretaudière France 19 215 0.4× 358 1.1× 223 0.7× 66 0.3× 16 0.1× 43 1.0k
Carolyn L. Orthner United States 14 429 0.8× 192 0.6× 27 0.1× 93 0.4× 95 0.5× 26 761

Countries citing papers authored by L.-O. Andersson

Since Specialization
Citations

This map shows the geographic impact of L.-O. Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.-O. Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.-O. Andersson more than expected).

Fields of papers citing papers by L.-O. Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.-O. Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.-O. Andersson. The network helps show where L.-O. Andersson may publish in the future.

Co-authorship network of co-authors of L.-O. Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of L.-O. Andersson. A scholar is included among the top collaborators of L.-O. Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.-O. Andersson. L.-O. Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andersson, L.-O., et al.. (2014). Development of an extremely fatigue-resistant Shock Absorber. Lund University Publications (Lund University). 67. 24–31. 1 indexed citations
2.
Ahmed, Tanveer, et al.. (1997). Inhibition of Antigen-Induced Acute Bronchoconstriction, Airway Hyperresponsiveness, and Mast Cell Degranulation by a Nonanticoagulant Heparin: Comparison With a Low Molecular Weight Heparin. American Journal of Respiratory and Critical Care Medicine. 155(6). 1848–1855. 40 indexed citations
3.
Falck, B., L.-O. Andersson, Anna Mikulowska, & G. Ronquist. (1993). alpha/Amino/n/butyric acid methyl ester induces concentrative uptake of L/dopa in human Langerhans' cells normally not operative for L/dopa transport.. Acta Dermato Venereologica. 73(3). 197–199. 6 indexed citations
4.
Andersson, L.-O., et al.. (1991). Immobilized metal ion affinity chromatography of serum albumins.. PubMed. 2(1). 15–22. 36 indexed citations
5.
Andersson, L.-O., et al.. (1991). Variables influencing the clot lysis assay of streptokinase. Thrombosis Research. 64(6). 713–721. 2 indexed citations
6.
Schrader, J, et al.. (1990). Lipolytic effects of heparin and low molecular weight heparin and their importance in hemodialysis.. PubMed. 16 Suppl. 41–5. 19 indexed citations
7.
Tengborn, Lilian, et al.. (1987). Properties and catabolism of heat treated antithrombin III concentrate. Thrombosis Research. 48(6). 701–711. 9 indexed citations
8.
Takahashi, Yukihiro, et al.. (1987). LOCALIZATION OF A FACTOR VIII BINDING DOMAIN ON THE N-TERMINAL PORTION (FRAGMENT SpIII) OF VON WILLEBRAND FACTOR. Thrombosis and Haemostasis. 2 indexed citations
9.
Andersson, L.-O., et al.. (1984). Elimination of high affinity heparin fractions and their anticoagulant and lipase activity. Blood. 63(4). 836–842. 17 indexed citations
10.
Brown, James E. & L.-O. Andersson. (1981). Interaction Of Factor VIII/Von Willebrand Factor With Phospholipid Vesicles. Thrombosis and Haemostasis. 4 indexed citations
11.
Andersson, L.-O., et al.. (1981). Presence Of Receptor For Activated Factor VIII On The Surface Of Released Platelets. Thrombosis and Haemostasis. 2 indexed citations
12.
Andersson, L.-O. & James E. Brown. (1981). Interaction of factor VIII-von Willebrand Factor with phospholipid vesicles. Biochemical Journal. 200(1). 161–167. 94 indexed citations
13.
Holmer, E., Ulf Lindahl, G. Bäckström, et al.. (1980). Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin. Thrombosis Research. 18(6). 861–869. 90 indexed citations
14.
Sandberg, H, et al.. (1980). Determination of platelet factor 3 in whole blood by a chromogenic peptide substrate assay. Thrombosis Research. 18(6). 871–882. 4 indexed citations
15.
Andersson, L.-O., Trevor W. Barrowcliffe, E. Holmer, Edward A. Johnson, & G.F. Soderstrom. (1979). Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma. Thrombosis Research. 15(3-4). 531–541. 142 indexed citations
16.
Borg, Håkan, et al.. (1978). Studies on human factor IX by immunoelectrophoretic and immunodiffusion methods. Thrombosis Research. 12(1). 131–139. 4 indexed citations
17.
Einarsson, Monica, et al.. (1976). Adsorption of hepatitis B surface antigen to matrix-bound long chain hydrocarbon structures. Cellular and Molecular Life Sciences. 32(4). 456–457. 3 indexed citations
18.
Andersson, L.-O., Håkan Borg, & Maggie Miller-Andersson. (1975). Purification and characterization of human factor IX. Thrombosis Research. 7(3). 451–459. 56 indexed citations
19.
Andersson, L.-O., Håkan Borg, & Marianne Mikaelsson. (1972). Molecular weight estimations of proteins by electrophoresis in polyacrylamide gels of graded porosity. FEBS Letters. 20(2). 199–202. 176 indexed citations
20.
Andersson, L.-O.. (1972). The Action and Inhibition of the Fibrinogen-Clotting Enzyme from the Venom of Trimeresurus Okinavensis. Pathophysiology of Haemostasis and Thrombosis. 1(2). 79–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026